Precirrhotic Primary Biliary Cholangitis with Portal Hypertension: Bile Duct Injury Correlate
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: The histological characteristics and natural history of precirrhotic primary biliary cholangitis (PBC) with portal hypertension (PH) are unclear. Our aim was to clarify the prevalence, risk factors, and histological characteristics of precirrhotic PBC patients with PH. Methods: This retrospective study compared the clinical features, histological characteristics, and response to ursodeoxycholic acid (UDCA) between the PH and non-PH groups of precirrhotic PBC patients. Results: Out of 165 precirrhotic PBC patients, 40 (24.2%) also had PH. According to histological stage 1, 2 and 3 disease, 5.3% (1/19), 17.3% (17/98), and 45.8% (22/48) of patients also had PH, respectively. Precirrhotic PBC with PH was significantly positively correlated with bile duct loss, degree of cytokeratin 7 positivity, and degree of fibrosis in the portal area, but significantly negatively correlated with lymphoid follicular aggregation. Compared to the non-PH group, patients in the PH group showed a higher prevalence of obliterative portal venopathy, incomplete septal fibrosis, portal tract abnormalities and non-zonal sinusoidal dilatation (p<0.05). In addition, patients with PH were more likely to present with symptoms of jaundice, ascites, epigastric discomfort, a poorer response to UDCA, and more decompensation events (p<0.05). High alkaline phosphatase levels, low white blood cell counts, high Mayo scores, and high FIB-4 index values were risk factors for precirrhotic PBC with PH. Conclusions: Approximately 24.2% of precirrhotic PBC patients have PH, which is histologically related to the injury of bile ducts. High alkaline phosphatase levels, low white blood cell counts, high Mayo scores, and high FIB-4 index values are associated with increased risk of precirrhotic PBC with PH.
Abstract
Background/Aims: The histological characteristics and natural history of precirrhotic primary biliary cholangitis (PBC) with portal hypertension (PH) are unclear. Our aim was to clarify the prevalence, risk factors, and histological characteristics of precirrhotic PBC patients with PH. Methods: This retrospective study compared the clinical features, histological characteristics, and response to ursodeoxycholic acid (UDCA) between the PH and non-PH groups of precirrhotic PBC patients. Results: Out of 165 precirrhotic PBC patients, 40 (24.2%) also had PH. According to histological stage 1, 2 and 3 disease, 5.3% (1/19), 17.3% (17/98), and 45.8% (22/48) of patients also had PH, respectively. Precirrhotic PBC with PH was significantly positively correlated with bile duct loss, degree of cytokeratin 7 positivity, and degree of fibrosis in the portal area, but significantly negatively correlated with lymphoid follicular aggregation. Compared to the non-PH group, patients in the PH group showed a higher prevalence of obliterative portal venopathy, incomplete septal fibrosis, portal tract abnormalities and non-zonal sinusoidal dilatation (p<0.05). In addition, patients with PH were more likely to present with symptoms of jaundice, ascites, epigastric discomfort, a poorer response to UDCA, and more decompensation events (p<0.05). High alkaline phosphatase levels, low white blood cell counts, high Mayo scores, and high FIB-4 index values were risk factors for precirrhotic PBC with PH. Conclusions: Approximately 24.2% of precirrhotic PBC patients have PH, which is histologically related to the injury of bile ducts. High alkaline phosphatase levels, low white blood cell counts, high Mayo scores, and high FIB-4 index values are associated with increased risk of precirrhotic PBC with PH.
참고문헌 (31)
- Galoosian A, "Clinical updates in primary biliary cholangitis : trends, epidemiology, diagnostics, and new therapeutic approaches", J Clin Transl Hepatol, 8, pp.49~60 (2020)
- Lleo A, "Changes in the epidemiology of primary biliary cholangitis", Clin Liver Dis, 22, pp.429~441 (2018)
- Lleo A, "Primary biliary cholangitis", Lancet, 396, pp.1915~1926 (2020)
- Tsuneyama K, "Primary biliary cholangitis : its pathological characteristics and immunopathological mechanisms", J Med Invest, 64, pp.7~13 (2017)
- Turco L, "Portal hypertension : pathogenesis and diagnosis", Clin Liver Dis, 23, pp.573~587 (2019)
- Arora S, "Portal hypertension in early-stage primary biliary cirrhosis : a possible explanation", Am J Gastroenterol, 82, pp.90~91 (1987)
- Ali AH, "Varices in early histological stage primary biliary cirrhosis", J Clin Gastroenterol, 45, pp.e66~e71 (2011)
- Ikeda F, "Prevalence and associated factors with esophageal varices in early primary biliary cirrhosis", J Gastroenterol Hepatol, 27, pp.1320~1328 (2012)
- Colina F, "Nodular regenerative hyperplasia of the liver in early histological stages of primary biliary cirrhosis", Gastroenterology, 102, pp.1319~1324 (1992)
- Navasa M, "Portal hypertension in primary biliary cirrhosis. Relationship with histological features", J Hepatol, 5, pp.292~298 (1987)
- Warnes TW, "Portal hypertension in primary biliary cholangitis : prevalence, natural history and histological correlates", Eur J Gastroenterol Hepatol, 33, pp.1595~1602 (2021)
- Lindor KD, "Primary biliary cholangitis : 2018 practice guidance from the American Association for the Study of Liver Diseases", Hepatology, 69, pp.394~419 (2019)
- De Gottardi A, "Porto-sinusoidal vascular disease : proposal and description of a novel entity", Lancet Gastroenterol Hepatol, 4, pp.399~411 (2019)
- Parés A, "Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid", Gastroenterology, 130, pp.715~720 (2006)
- Nakanuma Y, "Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens : interobserver agreement", Pathol Int, 60, pp.167~174 (2010)
- Scheuer PJ, "Classification of chronic viral hepatitis : a need for reassessment", J Hepatol, 13, pp.372~374 (1991)
- Kawata K, "The ursodeoxycholic acid response score predicts pathological features in primary biliary cholangitis", Hepatol Res, 51, pp.80~89 (2021)
- Heathcote J, "The clinical expression of primary biliary cirrhosis", Semin Liver Dis, 17, pp.23~33 (1997)
- Nakanuma Y, "Histological and histometric examination of the intrahepatic portal vein branches in primary biliary cirrhosis without regenerative nodules", Am J Gastroenterol, 77, pp.405~413 (1982)
- Abraham SC, "Liver transplantation in precirrhotic biliary tract disease : portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy", Am J Surg Pathol, 30, pp.1454~1461 (2006)
- de Franchis R, "Baveno VII : renewing consensus in portal hypertension", J Hepatol, 76, pp.959~974 (2022)
- Kim SH, "Esophageal varices in patients with cirrhosis : multidetector CT esophagography. Comparison with endoscopy", Radiology, 242, pp.759~768 (2007)
- Wan S, "Quantitative measurements of esophageal varices using computed tomography for prediction of severe varices and the risk of bleeding : a preliminary study", Insights Imaging, 13, pp.47~ (2022)
- Kihira S, "Non-invasive prediction of portal pressures using CT and MRI in chronic liver disease", Abdom Radiol(NY), 41, pp.42~49 (2016)
- Cansu A, "Diagnostic performance of using effervescent powder for detection and grading of esophageal varices by multi-detector computed tomography", Eur J Radiol, 83, pp.497~502 (2014)
- Zhang X, "Aberrant von Willebrand factor expression of sinusoidal endothelial cells and quiescence of hepatic stellate cells in nodular regenerative hyperplasia and obliterative portal venopathy", Histopathology, 76, pp.959~967 (2020)
- Liang J, "Key histopathologic features in idiopathic noncirrhotic portal hypertension : an interobserver agreement study and proposal for diagnostic criteria", Mod Pathol, 34, pp.592~602 (2021)
- Suzuki N, "Altered expression of alkaline phosphatase(ALP)in the liver of primary biliary cirrhosis(PBC)patients", Hepatol Res, 35, pp.37~44 (2006)
- Sakisaka S, "Alterations in tight junctions differ between primary biliary cirrhosis and primary sclerosing cholangitis", Hepatology, 33, pp.1460~1468 (2001)
- Saab S, "Portal hypertension", Clin Liver Dis, 23, pp.xiii~xiv (2019)
- Huet PM, "Portal hypertension and primary biliary cirrhosis : effect of long-term ursodeoxycholic acid treatment", Gastroenterology, 135, pp.1552~1560 (2008)